Garen Bohlin, Director at Tetraphase, holds 0.00 shares in Tetraphase (Ticker: TTPH), holds 52.47K shares in Collegium Pharmaceutical (Ticker: COLL), holds 45.14K shares in Karyopharm Therapeutics (Ticker: KPTI). Most recently, Garen Bohlin ― shares of Tetraphase on ― for an estimated value of ―.
Garen Bohlin latest transaction was an Uninformative Buy of ―.
What was Garen Bohlin's most profitable transaction?
Garen Bohlin’s most profitable transaction was an Informative Sell of COLL stock on May 16, 2024. The return on the trade was 4.40%.
What is Garen Bohlin's role in Tetraphase?
Garen Bohlin's role in Tetraphase is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.